Finance

Lists
Why is ANRO down 2,75%?
Dive Deeper
ANRO:NYSE
Alto Neuroscience Inc
US$25,86
-2,75%
(-0,73) 1D
30 ກ.ຍ., 15 ໂມງ 1 ນາທີ 21 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANRO...
Open
US$26,87
High
US$27,41
Low
US$25,85
Mkt. cap
1,01 ຕື້
Avg. vol.
532,46 ພັນ
Volume
234,15 ພັນ
52-wk high
US$37,48
52-wk low
US$4,00
EPS
US$-2,44
Shares outstanding
39,24 ລ້ານ
No. of employees
68
Open
US$26,87
High
US$27,41
Low
US$25,85
Mkt. cap
1,01 ຕື້
Avg. vol.
532,46 ພັນ
Volume
234,15 ພັນ
52-wk high
US$37,48
52-wk low
US$4,00
EPS
US$-2,44
Shares outstanding
39,24 ລ້ານ
No. of employees
68
About Alto Neuroscience Inc
CEO-
Employees68
Founded2019
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to ANRO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ANRO in the last 3 months.
Highest
Current US$25,86
US$55,00 (+112,68%)
Average
US$44,00 (+70,15%)
Lowest
US$37,00 (+43,08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
US$55,00
+112,7%
09/21/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
-
-
08/14/2026
Andrew Tsai
Jefferies
Buy
Maintained
US$40,00
+54,7%
08/13/2026
Thomas Shrader
BTIG
Buy
Reiterated
US$37,00
+43,1%
08/13/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
08/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
US$44,00
+70,1%
06/26/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
US$36,00
+39,2%
05/18/2026
Laura Chico
Wedbush
Hold
Maintained
US$24,00
-7,2%
05/14/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$30,00
+16%
04/21/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
US$33,00
+27,6%
04/02/2026
Last report
12 ສ.ຫ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$-0,65 / US$-0,77
+15,95%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,52 ລ້ານ
12,00 ລ້ານ
20,29 ລ້ານ
22,11 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,43 ລ້ານ
5,06 ລ້ານ
6,84 ລ້ານ
7,02 ລ້ານ
Operating expense
14,95 ລ້ານ
17,06 ລ້ານ
27,14 ລ້ານ
29,13 ລ້ານ
Total operating expenses
14,95 ລ້ານ
17,06 ລ້ານ
27,14 ລ້ານ
29,13 ລ້ານ
Operating income
-14,95 ລ້ານ
-17,06 ລ້ານ
-27,14 ລ້ານ
-29,13 ລ້ານ
Other non operating income
-112,00 ພັນ
-113,00 ພັນ
-115,00 ພັນ
-130,00 ພັນ
EBT including unusual items
-14,18 ລ້ານ
-16,18 ລ້ານ
-26,24 ລ້ານ
-27,64 ລ້ານ
EBT excluding unusual items
-14,18 ລ້ານ
-16,18 ລ້ານ
-26,24 ລ້ານ
-27,64 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,18 ລ້ານ
-16,18 ລ້ານ
-26,24 ລ້ານ
-27,64 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,52
-0,45
-0,80
-0,65
Interest and investment income
1,53 ລ້ານ
1,56 ລ້ານ
1,56 ລ້ານ
2,11 ລ້ານ
Interest expense
-650,00 ພັນ
-575,00 ພັນ
-545,00 ພັນ
-491,00 ພັນ
Net interest expenses
882,00 ພັນ
986,00 ພັນ
1,02 ລ້ານ
1,62 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,79 ລ້ານ
-16,90 ລ້ານ
-26,95 ລ້ານ
-28,94 ລ້ານ
Gain or loss from assets sale
114,00 ພັນ
-
9,00 ພັນ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google